Named after the Greek Fate who spins the thread of life, klotho is a protein discovered in 1997 when its absence in mice caused a syndrome of premature aging — osteoporosis, arteriosclerosis, skin atrophy, and early death. Conversely, overexpression extended mouse lifespan by 20-30%. Since then, klotho has become one of the most intensively studied longevity factors in biomedicine. Though technically a protein rather than a small peptide, its biology, research status, and therapeutic potential align it closely with the peptide medicine field.
Types of Klotho
There are three forms of klotho. Alpha-klotho is the best characterized and exists in two forms: a transmembrane form expressed primarily in kidney and brain, and a soluble form (sKlotho) cleaved from the membrane that circulates systemically and mediates most of the beneficial anti-aging effects. Beta-klotho and gamma-klotho have distinct roles in FGF signaling and uv protection.
Soluble alpha-klotho is the form targeted for therapeutic applications. It acts as a systemic hormone, circulating to organs including the brain, heart, kidney, and muscle.
Klotho and Phosphate Regulation
One of klotho's primary functions is co-receptor activity for FGF23, a hormone that regulates phosphate excretion by the kidneys. In klotho-deficient states, FGF23 cannot signal properly, causing phosphate to accumulate — driving vascular calcification, tissue aging, and organ dysfunction.
This phosphate toxicity mechanism explains many of the premature aging features seen in klotho-deficient mice and is increasingly recognized as a driver of accelerated aging in humans with kidney disease, where klotho levels plummet early in the disease course.
Cognitive and Brain Effects
Klotho has emerged as a critical factor in brain aging and cognitive resilience. Humans with a common klotho variant (KL-VS heterozygotes) have significantly higher circulating klotho levels and demonstrate better cognitive performance and reduced Alzheimer's risk — even in the presence of ApoE4, the strongest genetic Alzheimer's risk factor.
In aged mice, a single injection of soluble klotho protein at doses that raise blood levels modestly produces rapid and sustained improvements in synaptic plasticity and cognitive performance. This finding, published in Cell Reports, suggests klotho may enhance brain function acutely rather than requiring chronic administration.
Kidney and Cardiovascular Protection
Klotho is produced primarily in the kidney, and its levels fall early in chronic kidney disease (CKD). This decline accelerates disease progression through phosphate retention, FGF23 resistance, and inflammation. Supplementing klotho in CKD animal models slows disease progression, reduces fibrosis, and improves kidney function.
In the cardiovascular system, klotho suppresses vascular inflammation, inhibits endothelial cell senescence, and prevents vascular smooth muscle calcification. Low klotho is an independent predictor of cardiovascular mortality in both CKD patients and the general population.
How to Raise Klotho Levels
Given the challenges of delivering recombinant klotho protein (large molecule, poor bioavailability), several approaches to raise endogenous klotho are studied: exercise consistently increases klotho, particularly aerobic training. Vitamin D supplementation modestly raises klotho. Caloric restriction in animals boosts klotho expression. Some research suggests sirtuin activation (resveratrol, NAD+ precursors) may upregulate klotho, though human data are sparse.
Recombinant klotho protein is in early clinical trials for CKD and may eventually be available for age-related indications.
FAQ
Does klotho supplementation exist yet? Recombinant klotho is in Phase I/II trials for kidney disease. It is not commercially available. Raising endogenous klotho through exercise and vitamin D optimization is the current practical strategy.
What is a healthy klotho level? Reference ranges vary by assay. Typically, circulating sKlotho above 500-700 pg/mL is considered healthy in middle-aged adults. Levels decline approximately 10% per decade after age 40.
Can klotho reverse aging? In mice, klotho overexpression extends lifespan and reverses several aging hallmarks. Human evidence is observational. Therapeutic klotho is a genuine longevity candidate but remains experimental.
Related Articles
- GHK-Cu (Copper Peptide): Skin Regeneration and Anti-Aging
- Humanin: Mitochondrial Peptide Against Alzheimer's and Aging
- Afamelanotide: FDA-Approved Melanocyte Peptide
- AOD-9604: HGH Fragment for Fat Loss
- Argireline: The Topical Peptide Alternative to Botox?
Track your supplements in Optimize.
Related Supplement Interactions
Learn how these supplements interact with each other
Vitamin D3 + Vitamin K2
Vitamin D3 and Vitamin K2 are one of the most well-studied synergistic supplement pairings available...
Vitamin D3 + Magnesium
Vitamin D3 and Magnesium share a deeply interconnected metabolic relationship. Magnesium is a requir...
Omega-3 + Vitamin D3
Omega-3 fatty acids and Vitamin D3 are among the most commonly recommended supplements worldwide, an...
Zinc + Copper
Zinc and Copper have one of the most important antagonistic mineral interactions in nutrition. Chron...
Related Articles
More evidence-based reading
BPC-157 Complete Science Guide: Mechanism and Evidence
BPC-157 is a synthetic pentadecapeptide derived from gastric juice with remarkable tissue-healing properties across multiple organ systems.
5 min read →PeptidesBPC-157 and TB-500 Stack: Synergistic Tissue Repair
Combining BPC-157 and TB-500 targets tissue repair through complementary mechanisms — angiogenesis, cell migration, and growth factor signaling.
5 min read →PeptidesCJC-1295: Growth Hormone Releasing Hormone Analog
CJC-1295 is a GHRH analog that elevates GH and IGF-1 through pulsatile release, with DAC modification extending half-life to over a week.
5 min read →